Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4295747 Target Snapshot

Serine hydroxymethyltransferase, mitochondrial · SINGLE PROTEIN · Homo sapiens

322Compounds
6Assays
6Approved Drugs
282.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P34897. Use UniProt P34897 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P34897 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serine hydroxymethyltransferase, mitochondrial as ChEMBL target CHEMBL4295747, mapped to UniProt P34897. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serine hydroxymethyltransferase, mitochondrial
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4295747
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P34897
Serine hydroxymethyltransferase, mitochondrial
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serine hydroxymethyltransferase, mitochondrial is the right protein anchor across sources, using UniProt P34897 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSerine hydroxymethyltransferase, mitochondrial
UniProt AccessionP34897
Component TypeProtein
Sequence Length504 aa

Serine hydroxymethyltransferase, mitochondrial

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serine hydroxymethyltransferase, mitochondrial, mapped to UniProt P34897. Sequence length is 504 aa.

Mapped IDP34897
Review nameSerine hydroxymethyltransferase, mitochondrial
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

6
Approved
1
Phase III
Assay Mix

Activity Type Distribution

IC50262.0
KI18.0
KD2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5440815 7.8 Ki 16.0 Preclinical
CHEMBL5429283 7.22 Ki 60.0 Preclinical
CHEMBL5438587 7.1 Ki 80.0 Preclinical
CHEMBL5431881 6.47 Ki 340.0 Preclinical
CHEMBL5653589 6.46 Kd 345.44 Preclinical
CHEMBL506 6.36 IC50 436.52 Approved
CHEMBL5405010 6.35 Ki 450.0 Preclinical
CHEMBL5408906 6.34 Ki 460.0 Preclinical
CHEMBL4530254 6.27 IC50 540.0 Preclinical
CHEMBL5427804 6.2 Ki 630.0 Preclinical
Distribution

pChEMBL Value Distribution

110
5.0
74
5.5
12
6.0
0
6.5
2
7.0
1
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

Assay Landscape

Assay Landscape

6
Total Assays
255
Tested Compounds
1
Assay Types
Binding — 6 assays, 255 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 211 5.5
single protein format 2 44 4.8
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine